» Articles » PMID: 23347615

Evidence of Reactive Oxygen Species-mediated Damage to Mitochondrial DNA in Children with Typical Autism

Overview
Journal Mol Autism
Publisher Biomed Central
Date 2013 Jan 26
PMID 23347615
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled:

Background: The mitochondrial genome (mtDNA) is particularly susceptible to damage mediated by reactive oxygen species (ROS). Although elevated ROS production and elevated biomarkers of oxidative stress have been found in tissues from children with autism spectrum disorders, evidence for damage to mtDNA is lacking.

Findings: mtDNA deletions were evaluated in peripheral blood monocytic cells (PBMC) isolated from 2-5 year old children with full autism (AU; n = 67), and typically developing children (TD; n = 46) and their parents enrolled in the CHildhood Autism Risk from Genes and Environment study (CHARGE) at University of California Davis. Sequence variants were evaluated in mtDNA segments from AU and TD children (n = 10; each) and their mothers representing 31.2% coverage of the entire human mitochondrial genome. Increased mtDNA damage in AU children was evidenced by (i) higher frequency of mtDNA deletions (2-fold), (ii) higher number of GC→AT transitions (2.4-fold), being GC preferred sites for oxidative damage, and (iii) higher frequency of G,C,T→A transitions (1.6-fold) suggesting a higher incidence of polymerase gamma incorporating mainly A at bypassed apurinic/apyrimidinic sites, probably originated from oxidative stress. The last two outcomes were identical to their mothers suggesting the inheritance of a template consistent with increased oxidative damage, whereas the frequency of mtDNA deletions in AU children was similar to that of their fathers.

Conclusions: These results suggest that a combination of genetic and epigenetic factors, taking place during perinatal periods, results in a mtDNA template in children with autism similar to that expected for older individuals.

Citing Articles

Open-Label Sulforaphane Trial in FMR1 Premutation Carriers with Fragile-X-Associated Tremor and Ataxia Syndrome (FXTAS).

Santos E, Clark C, Biag H, Tang S, Kim K, Ponzini M Cells. 2023; 12(24).

PMID: 38132093 PMC: 10741398. DOI: 10.3390/cells12242773.


Signaling pathways in hair aging.

Liang A, Fang Y, Ye L, Meng J, Wang X, Chen J Front Cell Dev Biol. 2023; 11:1278278.

PMID: 38033857 PMC: 10687558. DOI: 10.3389/fcell.2023.1278278.


Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Opportunities.

Clemente-Suarez V, Redondo-Florez L, Beltran-Velasco A, Ramos-Campo D, Belinchon-deMiguel P, Martinez-Guardado I Biomedicines. 2023; 11(9).

PMID: 37760929 PMC: 10526226. DOI: 10.3390/biomedicines11092488.


New Views of the DNA Repair Protein Ataxia-Telangiectasia Mutated in Central Neurons: Contribution in Synaptic Dysfunctions of Neurodevelopmental and Neurodegenerative Diseases.

Briguglio S, Cambria C, Albizzati E, Marcello E, Provenzano G, Frasca A Cells. 2023; 12(17).

PMID: 37681912 PMC: 10486624. DOI: 10.3390/cells12172181.


Treatment of Autism Spectrum Disorders by Mitochondrial-targeted Drug: Future of Neurological Diseases Therapeutics.

Nabi S, Rehman M, Arafah A, Taifa S, Khan I, Khan A Curr Neuropharmacol. 2022; 21(5):1042-1064.

PMID: 36411568 PMC: 10286588. DOI: 10.2174/1570159X21666221121095618.


References
1.
Morton B, Bi I, McMullen M, Gaut B . Variation in mutation dynamics across the maize genome as a function of regional and flanking base composition. Genetics. 2005; 172(1):569-77. PMC: 1456184. DOI: 10.1534/genetics.105.049916. View

2.
. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Postgrad Med. 2002; 48(3):206-8. View

3.
Marcelino L, Thilly W . Mitochondrial mutagenesis in human cells and tissues. Mutat Res. 1999; 434(3):177-203. DOI: 10.1016/s0921-8777(99)00028-2. View

4.
Meng X, Zhu D, Ruan D, She J, Luo L . Effects of chronic lead exposure on 1H MRS of hippocampus and frontal lobes in children. Neurology. 2005; 64(9):1644-7. DOI: 10.1212/01.WNL.0000160391.58004.D4. View

5.
Boisse L, Mouihate A, Ellis S, Pittman Q . Long-term alterations in neuroimmune responses after neonatal exposure to lipopolysaccharide. J Neurosci. 2004; 24(21):4928-34. PMC: 6729381. DOI: 10.1523/JNEUROSCI.1077-04.2004. View